T2 Biosystems Raises $10.8 Million
T2 Biosystems Inc., a Cambridge, Mass.-based developer of portable medical diagnostic products that combine nanotech and miniaturized magnetic resonance technology, has raised $10.8 million in Series B funding. Partners Healthcare and In-Q-Tel were joined by return backers Flagship Ventures, Polaris Venture Partners and Flybridge Capital Partners.
17 October 2008•3 mins read
